Ruud P.M. Dings Data-verified

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

Federal Grant PI High Impact

Researcher

University of Arkansas UAMS primary

Last publication 2026 Last refreshed 2026-05-22

faculty

40 h-index 127 pubs 5,190 cited

Research Areas

Links

ORCID Google Scholar Lab Website Research Group

OverviewAI-generated summary

Ruud P.M. Dings' research focuses on the intersection of cancer biology, immunology, and therapeutic development. His work investigates mechanisms of tumor growth, immune evasion, and the response of cancer cells and their microenvironment to various treatments, including radiation therapy, targeted therapies, and nanoparticle-based interventions.

Dr. Dings has explored the inflammatory activities associated with VEGF-targeted treatments and how they can reverse tumor endothelial cell anergy. His research also examines the bystander effects of spatially fractionated radiation therapy, considering its implications from molecular to organismal levels. He has investigated the role of galectins in cellular networks, revealing synergistic activities when mixed in vitro, and has contributed to the nanoscale investigation and control of photothermal effects using gold nanostructures. Additionally, his work has explored how dysbiotic stress influences tumor vasculature sensitivity to radiotherapy and c-Met inhibitors, and the biocompatibility of materials for dendritic cell applications.

With an h-index of 39 and over 5,000 citations across 123 publications, Dr. Dings is recognized as a highly cited researcher. He leads a research group and actively collaborates with researchers at the University of Arkansas for Medical Sciences, including Samir V. Jenkins and Robert J. Griffin, as well as Narasimhan Rajaram at the University of Arkansas.

Metrics

h-index: 40
Publications: 127
Citations: 5,190

Selected Publications

Abstract 4785: Thermal regulation of dysbiotic tumor vasculature (2026)

DOI OpenAlex
Abstract 7625: Development of a blood-based tumor hypoxia detection assay (2026)

DOI OpenAlex
Modified tumor uptake and biodistribution of nanoparticles coated with small extracellular vesicle membranes derived from distinct tumor cell lines (2026)

DOI OpenAlex
Investigating Biomarkers of Radiation Resistance in Head and Neck Cancer Using Raman Spectroscopy (2025)

DOI OpenAlex
Bystander Effects in Spatially Fractionated Radiation Therapy: From Molecule To Organism To Clinical Implications (2024)

9 citations DOI OpenAlex
Morphological Effects and In Vitro Biological Mechanisms of Radiation-Induced Cell Killing by Gold Nanomaterials (2023)

2 citations DOI OpenAlex
Proinflammatory activity of VEGF-targeted treatment through reversal of tumor endothelial cell anergy (2022)

46 citations DOI OpenAlex
Abstract 3529: T-cell trafficking and extravasation is suppressed in distal tumors during gastrointestinal tract dysbiosis (2022)

DOI OpenAlex
Gold nanorods enhance different immune cells and allow for efficient targeting of CD4+ Foxp3+ Tregulatory cells (2021)

5 citations DOI OpenAlex
Nanoscale investigation and control of photothermal action of gold nanostructure-coated surfaces (2021)

7 citations DOI OpenAlex
Dysbiotic stress increases the sensitivity of the tumor vasculature to radiotherapy and c-Met inhibitors (2021)

4 citations DOI OpenAlex
Dendritic cell biocompatibility of ether‐based urethane films (2021)

3 citations DOI OpenAlex